Abstract:To evaluate the value of radiomics for survival analysis and prediction of glioblastoma (GBM) patients treated with chemoradiation therapy (CRT). Twenty-eight newly diagnosed GBM patients who received CRT at our institution between 2008 and 2014 were retrospectively studied. In addition to demographics (age, race, gender) and clinical parameters (KPS, extent of resection, radiation therapy type, dose and status, whether concurrent temozolomide was adjusted/stopped), 255 imaging features were extracted from 3 gadolinium-enhanced T1 weighted MRIs for 2 regions of interest (ROIs) (the surgical cavity and its surrounding enhancement rim). The 3 MRIs were at post-operation, 1-month and 3-month post-CRT. For the radiomics approach, imaging features comprehensively quantified the intensity, spatial variation (texture), geometric property, and their spatial-temporal changes for the 2 ROIs. Overall survival (OS) and progression-free survival (PFS) were analyzed using univariate and multivariate analysis. Machine learning models (logistic regression (LR), support vector machine (SVM), decision tree (DT), neural network (NN)) were applied to evaluate the survival prediction capability of algorithmically selected features. The number of cases and percentage of cases predicted correctly were collected and AUC (area under the receiver operating characteristic (ROC) curve) were determined after leave-one-out cross-validation. For univariate survival analysis, 28 features (1 demographic, 2 clinical and 25 imaging) were statistically significant (P<0.05) for both OS and PFS. The types of imaging features were volumetric, intensity, geometry, texture and their spatial-temporal changes. For multivariate survival analysis, 14 of the features remained statistically significant (P<0.05) for OS and 20 features remained statistically significant (P<0.01) for PFS. When all the features were used by machine learning models to predict the survival, 24 features were algorithmically selected. High prediction accuracy of OS was achieved by using NN (96%, 27 of 28 cases were correctly predicted, AUC = 0.99), LR (93%, 26 of 28 cases were correctly predicted, AUC = 0.95) and SVM (93%, 26 of 28 cases were correctly predicted, AUC = 0.90). When predicting PFS, NN obtained the highest prediction accuracy (89%, 25 of 28 cases were correctly predicted, AUC = 0.92). In this preliminary study, radiomics approach combined with patients’ demographics and clinical parameters are promising (even MGMT status was not available) for survival analysis and prediction in GBM patients treated with CRT. To achieve more accurate predictions, advanced machine learning models should be considered.

An automatic deep learning-based workflow for glioblastoma survival prediction using pre-operative multimodal MR images

Pre-operative Overall Survival Time Prediction for Glioblastoma Patients Using Deep Learning on Both Imaging Phenotype and Genotype

A Deep Learning Model with Radiomics Analysis Integration for Glioblastoma Post-Resection Survival Prediction

An Automated Approach for Predicting Glioma Grade and Survival of LGG Patients Using CNN and Radiomics.

Automated Neural Network-based Survival Prediction of Glioblastoma Patients Using Pre-operative MRI and Clinical Data

Multiple Survival Outcome Prediction of Glioblastoma Patients Based on Multiparametric MRI

Predicting Overall Survival of Glioblastoma Patients Using Deep Learning Classification Based on MRIs

Non‐invasive prediction of overall survival time for glioblastoma multiforme patients based on multimodal MRI radiomics

Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages

Radiomics for Survival Analysis and Prediction in Glioblastoma (GBM)—A Preliminary Study

Overall Survival Time Prediction of Glioblastoma on Preoperative MRI Using Lesion Network Mapping

Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma

Radiomics-Based Machine Learning with Natural Gradient Boosting for Continuous Survival Prediction in Glioblastoma

A novel 3D multi-path DenseNet for improving automatic segmentation of glioblastoma on pre-operative multi-modal MR images

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme

Ensemble Learning for Glioma Patients Overall Survival Prediction Using Pre-Operative MRIs

Combined use of radiomics and artificial neural networks for the three‐dimensional automatic segmentation of glioblastoma multiforme

Dynamic architecture based deep learning approach for glioblastoma brain tumor survival prediction

Handcrafted and Deep Learning-Based Radiomic Models Can Distinguish GBM from Brain Metastasis

Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma

Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics